Postoperative detection of α-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma

被引:24
作者
Minata, M
Nishida, N
Komeda, T
Azechi, H
Katsuma, H
Nishimura, T
Kuno, M
Ito, T
Yamamoto, Y
Ikai, I
Yamaoka, Y
Fukuda, Y
Nakao, K
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068397, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kyoto, Japan
[3] Kyoto Univ, Coll Med Technol, Kyoto 606, Japan
关键词
alpha-fetoprotein mRNA; hepatocellular carcinoma; metastatic recurrence; surgery;
D O I
10.1046/j.1440-1746.2001.02461.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We tested for the presence of alpha-fetoprotein (AFP) mRNA by using nested RT-PCR in the peripheral blood of hepatocellular carcinoma (HCC) patients who had undergone curative surgery, and investigated the occurrence of intrahepatic and/or extrahepatic metastasis thereafter, to reveal the optimal timing of blood sampling for the prediction of metastatic recurrence. Methods: Twenty-nine patients with HCC, who had been operated on were analyzed with RT-PCR at several points during the clinical course, and examined for metastatic recurrence for 3-28 months (mean = 18.7 months) after surgery. Results: The presence of AFP mRNA before surgery was significantly correlated with the tumor size (P = 0.017). Metastatic recurrence was associated with the postoperative detection of AFP mRNA (P < 0.001), but not with the preoperative and/or perioperative detection. Furthermore, AFP mRNA was detected in some cases that showed low serum AFP levels at recurrence. The recurrence-free period after the detection of AFP mRNA varied from 1 to 12 months. Conclusions: The postoperative detection of AFP mRNA is useful for the prediction of metastatic recurrence, and long-term follow up with this method should be conducted. (C) 2001 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 28 条
  • [1] RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA
    ADACHI, E
    MAEDA, T
    MATSUMATA, T
    SHIRABE, K
    KINUKAWA, N
    SUGIMACHI, K
    TSUNEYOSHI, M
    [J]. GASTROENTEROLOGY, 1995, 108 (03) : 768 - 775
  • [2] [Anonymous], 1990, ANN SURG, V211, P277
  • [3] Ezaki T, 1996, J SURG ONCOL, V62, P115
  • [4] Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver
    Funaki, NO
    Tanaka, J
    Seto, SI
    Kasamatsu, T
    Kaido, T
    Imamura, M
    [J]. HEPATOLOGY, 1997, 25 (03) : 564 - 568
  • [5] IKEDA K, 1993, CANCER, V71, P19, DOI 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO
  • [6] 2-I
  • [7] Ikeda Y, 1995, HEPATO-GASTROENTEROL, V42, P469
  • [8] JIANG SY, 1995, BRIT J CANCER, V75, P928
  • [9] Non-specificity of messenger RNA of α-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans
    Kedda, MA
    Kew, MC
    Skelton, M
    Hodkinson, J
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (09) : 885 - 891
  • [10] KOMEDA T, 1995, CANCER-AM CANCER SOC, V75, P2214, DOI 10.1002/1097-0142(19950501)75:9<2214::AID-CNCR2820750905>3.0.CO